University of California San Francisco

CIRM grantee Robert Blelloch wins ISSCR Outstanding Young Investigator Award

CIRM grantee Robert Blelloch of the University of California, San Francisco won the 2011 Outstanding Young Investigator Award from the International Society for Stem Cell Research. The society's annual meeting is taking place now in Toronto.

Blelloch presented his research June 15 at 6pm and will participate in a press briefing at noon June 16. His work focuses on the role of small molecules called microRNAs and their role in stem cell biology and cancer.

Top four list: why embryonic stem cells are critical

Yesterday CIRM grantee Bruce Conklin gave his top four reasons why embryonic stem cells are so valuable and why federal funding for the work needs to be able to continue. Conklin, who is Senior Investigator Gladstone Institute of Cardiovascular Disease and professor at UCSF, studies heart rhythm defects by creating iPS cells from people genetically predisposed to have those defects, then maturing those into heart cells in a dish.

Nobel prize winner Stanley Prusiner calls for Alzheimer's disease funding

Nobel Prize winner Stanley Prusiner was one of the authors on a letter to the New York Times on October 27 advocating that congress pass legislation that "would raise the annual federal investment in Alzheimer's research to $2 billion, and require that the president designate an official whose sole job would be to develop and execute a strategy against Alzheimer's."

The University of California enters stem cell funding battle

The University of California has now entered the stem cell funding legal fracas, filing a motion to participate in the pending lawsuit. In a statement, the UC Office of the President said they are the first institution to seek to intervene in the lawsuit:

Resting stem cells are cancer-prone

CIRM grantees at University of California, San Francisco, have published a Cell Stem Cell paper explaining why blood-forming stem cells accumulate cancer-causing mutations with age. Basically, they found that inactivity is genetically risky for the cells.

Shinya Yamanaka receives Kyoto prize for reprogramming skin cells

Last week, while stem cell researchers from around the world congregated in San Francisco for their annual meeting, stem cell pioneer Shinya Yamanaka won the Kyoto Prize for Advanced Technology. This award in generally considered to be a precursor to a Nobel Prize.

A press release from UCSF said:


Subscribe to RSS - University of California San Francisco

© 2013 California Institute for Regenerative Medicine